The purpose of this study was to investigate the effect of hippotherapy sessions on mental well-being of patients with paranoid schizophrenia and patients with acute and transient psychotic disorders who were hospitalized in a psychiatric hospital. We have found that hippotherapy significantly increased well-being of these patients and that the effect was increasing with repeated sessions.
We selected five characteristics of well-being based on our 14-year experience of treating patients with schizophrenia. We focused especially on certain features of emotion (mood, fear, psychic tension) and of social areas (contacts, communication). The patients spoke most often about these subjective feelings during hippotherapy. We also considered that schizophrenia is characterized by disturbed thinking, perception and personality. Schizophrenia results in deficit in patient’s ability to understand world, behave rationally, and act and succeed in life (
9).
Most common experience that patients with schizophrenia during hippotherapy mention was mood, which the disease changed towards depressive and anxious states. In our experience, it is optimal if hippotherapy occurs in natural surroundings and in a safe group without white coats. The therapy takes into account individual needs of participants and from the beginning tries to motivate every patient. It is very important that every patient has a positive experience that he later interprets and shares with others. Very important is, if he speaks about enjoying it.
The patient is more open to communication and feelings because of the experience with a horse, the therapist and the group. The horse can focus his interest and distract him from his problems. The horse considers the patient as an equal partner and allows him to recognize and experience his identity. Experience in a stable and with a horse leads to increased emotions of the patient that is reflected in his verbal communication, mentioning improved mood and feeling of release. The release of psychic tension may be related to the improved mood. Patients report that this condition lasts several hours after ending hippotherapy.
Patients with paranoid schizophrenia and psychotic disorder who are provided hippotherapy speak rarely about feeling of fear. That is probably because the disease decreases the ability to read signals from the environment. Therefore, they cannot adjust their actions because they miss a healthy respect. In hippotherapy, we are using the word respect instead of fear. Development of a healthy respect towards the horse is very often related to behavioral limits of the patient. If the patient has tendency to cross his limits, the horse reacts to that sensitively and modify his behavior to one acceptable to the environment. On the other hand, if the patient is withdrawn, the horse activates him by his curiosity and need for contact. According to our experience, the horse obtains respect from the patient naturally, due to its size, neutrality and show of force. The patient almost always responds to non-verbal expression of the horse and later shares the experiences, emotions and feelings with the therapist and the group.
Hippotherapy in psychiatry is always based on individual goals and needs of the patient. Marianne Gang talks about so-called borderline experience where patients have the opportunity during various activities with horses to explore their own possibilities and limits, which allows them a high emotional involvement (
10). Work with emotions, feelings and communication is essential to the therapeutic process of hippotherapy in psychiatry. In agreement with some reports (
5,
6), we found improvement in negative symptoms of schizophrenia, self-confidence and social functioning.
Our study has several limitations. We did not use a validated evaluation scale but designed one from our clinical experience. However, out scale had very good reliability. We concentrated on evaluation of hippotherapy effect on well-being and did not collect data regarding drug administration and hospital admission. We evaluated effects of only 6 therapeutic units and the relatively short duration of the study may not have an effect on these variables. The patients served as their own controls and we cannot exclude longitudinal changes in disease symptomatology. There is a need for longer study that would evaluate effects of hippotherapy in schizophrenia by a randomized control methodology and collect information about several clinical outcomes.